Evidence map›Paper›PMID 42253902›Full record

ArticleReproductive medicine and biology

Transfer Strategy Minimizing Twin Risk of Double Blastocyst Transfers Based on Prediction Models.

Kazuma Onishi, Daichi Inoue, Yuta Kida, Masae Kojima, Noritaka Fukunaga, Yoshimasa Asada

Abstract read
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kazuma OnishiAsada Ladies Clinic Nagoya Aichi Japan.ORCID https://orcid.org/0000-0002-2054-4684
Daichi InoueAsada Ladies Clinic Nagoya Aichi Japan.ORCID https://orcid.org/0000-0002-1832-8405
Yuta KidaAsada Institute for Reproductive Medicine Kasugai Aichi Japan.
Masae KojimaAsada Institute for Reproductive Medicine Kasugai Aichi Japan.
Noritaka FukunagaAsada Institute for Reproductive Medicine Kasugai Aichi Japan.
Yoshimasa AsadaAsada Ladies Clinic Nagoya Aichi Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To develop a simulation model to guide single embryo transfer (SET) versus double embryo transfer (DET) decisions by minimizing twin risk per transfer while maintaining treatment efficiency. Methods: This retrospective observational study included individuals undergoing SET or DET with frozen blastocysts in hormone replacement therapy. Three generalized estimating equation-based models were developed: ongoing pregnancy after SET (Model 1) and DET (Model 2), and twin pregnancy after DET (Model 3). Model 1 was constructed using propensity score-matched SETs comparable to DETs. The simulation aimed to identify the optimal transfer sequence for patients with multiple blastocysts using a stepwise optimization that selects SET or DET at each transfer while maximizing pregnancy probability and constraining twin risk below predefined thresholds. Results: 5721 DET and 5719 matched SET cycles were included in the analysis. The ongoing pregnancy rate was 20.1% in matched SET and 25.1% in DET, while the ongoing twin pregnancy rate following DET was 5.5%. Area under the curve was 0.77, 0.73, and 0.82 for Model 1-3, respectively. Simulation demonstrated an optimal sequence combining SET/DET under the individualized twin risk in a variety of scenarios (https://sites.google.com/view/det-simulator/). Conclusions: This model supports individualized embryo transfer planning by balancing treatment efficiency and twin risk.

Indexed as

algorithmdecision curve analysismodelpredictionsimulation

Identifiers

PMID42253902
PMCPMC13239488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.